PharmAthene, Inc. (AMEX: PIP) develops and commercializes medical countermeasures against biological and chemical weapons. The Company’s lead product development programs include: SparVax™, a second generation recombinant protective antigen anthrax vaccine; Valortim®, for the prevention and treatment of anthrax infection; and Recombinant BChE for the prevention and treatment of morbidity and mortality associated with exposure to chemical nerve agents. For further information, visit the Company’s Web site at www.PharmAthene.com.

Noble Financial, a research driven, full-service investment banking boutique, is as discriminating with its invitations to institutional investors as it is with the companies invited to present. Rather than just focusing on crowding the conference floor, Noble Financial carefully invites a smaller audience of investors with a large appetite for the companies presenting; quality always trumps quantity. For more information or to view webcasts of today’s presentations, visit www.noblefcm.com.

Let us hear your thoughts below: